8
Oct
2024

Knight (Brazil)

Exhibitor at CPHI Milan 2024 stand 14D40, Finished Dosage Formulations
About Us

Knight Therapeutics Inc. is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals in Canada and Latin America. Headquartered in Montreal, Knight has operations in Canada and in 10 countries in Latin America and has over 700 employees globally. Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD.

  • BR
  • 2024
    On CPHI since
  • 500 - 999
    Employees
Company types
Licensee
Primary activities
Pharmaceutical Company (innovator finished products)
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 14D40, Finished Dosage Formulations